MENU

Parathyroidism: Hypo, Hyper....what is normal, really?

Sponsored by: DiaSorin
Speaker
  • Division Head, Bone and Mineral Metabolism, Henry Ford Health System
    Biography

      Dr. Rao is the Section Head, Bone & Mineral Metabolism & Director of Bone & Mineral Research Laboratory, Henry Ford Hospital, Detroit, MI, USA, a position he has held continuously since 1995. It is the best bone histomorphometry lab in the state, and one of the best in the country. Under his direction, the lab has been conducting both basic and clinical research, and published extensively on the pathogenesis of bone fragility, age related bone loss, mechanism of atypical fractures, role of vitamin D in parathyroid adenoma size and disease expression, and on parathyroid tumorigenesis.


      Dr. Rao has more than 100 peer reviewed papers, 100 symposium proceedings, abstracts, and letters to the editor, and 10 book chapters. He is a founding member of the Indian Society of Bone & Mineral Research, which he helped launch in 1997.


      Dr. Rao has received a number of awards including the Willard O. Thomson travelling scholar award from the American college of Physicians in 1986, the Boy Frame award from the American Society for Bone and Mineral Research in 1999. He is a fellow of the American College of Physicians (FACP) and of the American Association of Clinical Endocrinologists (FACE)


    Abstract

    Hyper and Hypoparathyroid disease states are often latent with a multiplicity of manifestations ranging from asymptomatic state to obvious symptoms and complications such as fatigue, depression, kidney stones, bone fractures and intracranial calcifications.  Both conditions are associated with significant morbidity related to cardiac and vascular calcifications, hypertension, and seizure disorders.  As Dr. Rao picks up the normality enigma, the altered parathyroid state and its importance will be addressed diagnostically as it applies to the choices made in the course of clinical management.


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    SEP 03, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 03, 2020 9:00 AM PDT
    DATE: September 3, 2020 TIME: 09:00am PT, 12:00pm ET xxx Learning Objectives: xxx Webinars will be available for unlimited on-demand viewing after live event. LabRoots is approved as a provi...
    C.E. CREDITS
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    JUN 17, 2020 1:30 PM PDT
    C.E. CREDITS
    JUN 17, 2020 1:30 PM PDT
    Understanding the complex interplay between a pathogen and the host response is important to developing effective vaccines and therapeutics. The nCounter® Analysis System and GeoMx®...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    Loading Comments...
    Show Resources
    Attendees
    • See more